Products and services that have material impact on basic needs and livelihoods and address a core draw on a consumer’s time, money or energy present great opportunities.
“I spend a lot of time being angry — but I’m still hopeful. Gender bias in medicine is systemic,” says Carine Carmy, the fast-talking CEO and co-founder of Origin, during a con
London-based femtech hardware startup Astinno has picked up an Innovate UK grant worth £360k ($450k) to fund further testing of a wearable it’s developing for women experiencing a perimenopause
We spoke to CEOs and founders about how their companies have evolved from first entering the space and feeling like an island to now -- a community of women changing the world for women.
Mangrove Capital Partners’ co-founder and CEO Mark Tluszcz is brimming with enthusiasm for what’s coming down the pipe from health tech startups. Populations armed with mobile devices and hung
U.S. femtech startup CurieMD is offering menopause diagnosis and treatment prescription via a telehealth platform — beginning in California, where it launched late last year. Founder Dr. Leslie Mese
U.K. startup Daye is rethinking female intimate care from a woman’s perspective, starting with a tampon infused with cannabidiol that tackles period pain. It’s also quietly demolishing the retrogr
Early-stage European VC firm Blossom Capital is fresh from closing a $185M fund— a big jump up on its prior close. The firm makes just a handful of investments per year, mostly at the Series A stage
London-based seed fund LocalGlobe is incredibly active at the early-stage end of the startup pipeline with a broad focus across multiple sectors and areas, including health. We interviewed partner Jul
Berlin-based femtech startup Inne is coming out of stealth to announce an €8 million (~$8.8M) Series A and give the first glimpse of a hormone-tracking subscription product for fertility-tracking an
Across the political, social and economic stage, women’s issues are finally receiving heightened attention and priority. What’s driving so much positive change?
A number of promising women’s health tech companies have popped up in the last few years, from fertility apps to ovulation bracelets — even Apple has jumped into the subject with the addit
Daye, a “femcare” startup developing a new type of tampon that uses CBD to help tackle dysmenorrhea, has quietly raised $5.5 million in funding from high-profile investors in the U.S. and
Cora, which sells organic tampons and pads, has raised $7.5 million. It's the latest in a long series of deals in the femtech space.
Elvie has created a silent wearable breast pump and a smart pelvic floor exerciser.
There’s no shortage of so-called femtech startups raising money right now, and little wonder why. Aside from the growing market opportunity — the global fertility services market is expect
We explored venture capitalists' latest bets on fertility and contraception tech, including Modern Fertility, Extend Fertility, Natural Cycles, Nurx, Clue and more.
Hims has a new women's brand offering birth control, the 'female viagra,' shampoo, skin care and more.
Femtech startup Clue is looking at expanding the feature-set of its period tracking app to attract women outside its current younger demographic.
Elvie, the maker of a connected pelvic floor trainer that helps women with bladder control and yes, even better sex, has proven there’s a market for so-called “femtech” devices. Afte